Thermo Fisher Opens Cryo-EM Drug Discovery Center in SF
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
March 3, 2026 Insilico Medicine, a clinical-stage biotechnology company known for its generative artificial intelligence platforms, has launched a...
Toronto, Canada — February 26, 2026 Xtalks has announced an upcoming webinar highlighting how an ecosystem-driven, AI-enabled Electronic Lab...
SOUTH SAN FRANCISCO, Calif., August 19, 2025 – Convoke, an AI-native operating system for the biopharmaceutical industry, today announced...
